SARS-CoV-2-INDUCED MICROSCOPIC POLYANGIITIS: CLINICAL PROBLEM
Introduction. During the COVID-19 pandemic, the diagnosis and treatment of ANCA-associated vasculitis (AAV) have been discussed in different ways. At the same time, the authors of many foreign publications state that SARS-CoV-2 infection can be another viral trigger for the development of AAV in chi...
Saved in:
Main Authors: | Olga O. Gutsalenko, Borys M. Fylenko, Tetyana I. Yarmola, Nataliia V. Roiko, Iryna V. Tsyganenko |
---|---|
Format: | Article |
Language: | English |
Published: |
State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department
2025-05-01
|
Series: | Клінічна та профілактична медицина |
Subjects: | |
Online Access: | https://cp-medical.com/index.php/journal/article/view/599 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01) -
Microscopic polyangiitis: Modern concepts and treatment options
by: I. T. Murkamilov, et al.
Published: (2021-10-01) -
Livedo racemosa as the presenting symptom of microscopic polyangiitis
by: Christine Li, BS, et al.
Published: (2025-09-01) -
Clinical and immunological variants of ANCA-associated systemic vasculitis: a look at the pulmonary fibrosis in microscopic polyangiitis with anti-myeloperoxidase antibodies and rheumatoid factor. Literature review and own observation
by: T. V. Beketova, et al.
Published: (2023-03-01) -
International guidelines for the management ofANCA-associated systemic vasculitides
by: T. V. Beketova
Published: (2019-03-01)